Monthly Archives: October 2024

Update 31/10/204 – This recall notification has been updated since its initial publication on 29 October 2024 to include the correct description for Labetalol 200mg Tablets. Tillomed Laboratories Limited erroneously provided incorrect information pertaining the description and have ensured that all other information is correct. Please ensure that appropriate action is taken. Drug alert number: [...]

The post MHRA Class 2 Medicines Recall: Labetalol 200mg Tablets (Tillomed Laboratories Limited) – Update appeared first on Community Pharmacy England.

More than 1.3 million unfunded consultations a week – or just over 69 million a year – are now being carried out by community pharmacy teams in England, according to Community Pharmacy England’s 2024 Pharmacy Advice Audit. This is nearly 50% more consultations than in 2020, and is despite the introduction of the Pharmacy First [...]

The post Pharmacies in England provide nearly 70 million unfunded consultations a year appeared first on Community Pharmacy England.

iNews The findings from Community Pharmacy England’s 2024 Pharmacy Advice Audit, released today, highlight that pharmacies are providing several million walk-in consultations each year. Our report shows the scale of underfunded work pharmacies are taking on, including the number of GP appointments they are saving the NHS annually, and the huge demand pharmacies in England [...]

The post Pharmacies are saving the NHS 38 million GP appointments a year appeared first on Community Pharmacy England.

Community Pharmacy England has released a series of resources to help further promote the Flu Vaccination Service to patients and members of the public. Community pharmacy owners and their teams are working extremely hard to provide the flu vaccination service in a more compressed time scale this year. The change in the timing follows clinical [...]

The post Flu vac: resources to promote the service appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Drug alert number: EL (24)A/51 Date issued: 28 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Company name: Kent Pharma UK Product [...]

The post MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) appeared first on Community Pharmacy England.